by Chris Barry | May 5, 2023 | News
We’re thrilled to announce that ReNewVax has been shortlisted as one of the finalists to present a pitch at the 2023 BIO International Convention in Boston, Massachusetts. Taking place from 5th –8th June, the BIO International Convention is the world’s largest...
by Chris Barry | May 5, 2023 | News
Our Chief Scientific Officer Dr. Marie O’Brien was invited to appear on The Northern Agenda’s second birthday podcast! This episode saw hosts Rob Parsons and Dan McLaughlin discuss the last two years in Northern politics and ask whether the North is still a priority...
by Chris Barry | Apr 28, 2023 | News
World Immunization Week Q&A with Dr Marie O’Brien World Immunization Week, celebrated in the last week of April, aims to highlight the collective action needed to protect people from vaccine-preventable diseases. Here, our chief scientific officer Dr Marie...
by Chris Barry | Apr 26, 2023 | News
Our chief scientific officer Dr Marie O’Brien is featured in the April/May edition of Laboratory News discussing ReNewVax’s RVX-001 pneumococcal vaccine program. In the article, Dr O’Brien explores how we are deploying novel platform technology for vaccine design...
by Marie O'Brien | Jul 28, 2022 | News
We are very excited to announce that ReNewVax Ltd is now a proud member of Bionow. Bionow supports business growth, competitiveness and innovation within the biomedical and life science sectors across Northern England (https://www.bionow.co.uk/). Bionow currently have...
by Marie O'Brien | Jul 17, 2022 | News
ReNewVax will attend BIO-Europe in Leipzig, Germany on October 24th-26th, 2022. The event is expected to gather over 4,000+ global biopharma executives. We will be particularly focussed on the themes Respiratory and Infectious diseases, Immune profiling, Vaccine...
